ACHE and Alzheimer disease: Three acetylcholinesterase inhibitors (AChEIs; donepezil, galantamine, and rivastigmine) and memantine have been shown to slow cognitive deterioration in people with Alzheimer’s disease (AD) and are considered ‘usual care’ for this group of patients in the UK [6–8].